Stephen Neeleman - Jun 5, 2024 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
FOUNDER AND VICE CHAIRMAN, Director
Signature
/s/ Stephen Neeleman
Stock symbol
HQY
Transactions as of
Jun 5, 2024
Transactions value $
-$1,778,948
Form type
4
Date filed
6/7/2024, 03:43 PM
Previous filing
Jun 6, 2024
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $351K +25K +27.66% $14.00 116K Jun 5, 2024 Direct F1
transaction HQY Common Stock Sale -$2.13M -25K -21.67% $85.06 90.5K Jun 5, 2024 Direct F1, F2
holding HQY Common Stock 559K Jun 5, 2024 See footnote F3
holding HQY Common Stock 203K Jun 5, 2024 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Option (right to buy) Options Exercise $0 -25K -35.97% $0.00 44.6K Jun 5, 2024 Common Stock 69.6K $14.00 Direct F1, F5
holding HQY Stock Option (right to buy) 19.9K Jun 5, 2024 Common Stock 19.9K $41.28 Direct F5
holding HQY Stock Options (right to buy) 14.2K Jun 5, 2024 Common Stock 14.2K $61.72 Direct F5
holding HQY Stock Options (right to buy) 15.3K Jun 5, 2024 Common Stock 15.3K $73.61 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 08, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3 Shares held of record by the Stephen and Christine Neeleman Trust.
F4 Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
F5 The option is immediately exercisable.